secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nemaura Medical Inc. (—)
CIK:        0001602078
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001079973-23-000298
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nemaura Medical receives Nasdaq non-compliance notice for late 10-Q, regained compliance after filing
--------------------------------------------------------------------------------

- Nasdaq notified Nemaura on Feb 23, 2023 of failure to timely file Form 10-Q for quarter ended Dec 31, 2022.
- Company filed the overdue Form 10-Q on Feb 24, 2023.
- Nasdaq confirmed compliance on Feb 27, 2023 and closed the matter.
- Press release issued March 9, 2023 to disclose the notice and resolution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1602078/000107997323000298/0001079973-23-000298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1602078/000107997323000298/nmra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-000298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer